Respiratory and Limb Muscle Dysfunction in COPD.

Area of Science:

• Pulmonary Medicine
• Muscle Physiology
• Systemic Manifestations of COPD

Background:

• Chronic Obstructive Pulmonary Disease (COPD) is a leading global cause of death.
• Muscle dysfunction, affecting both respiratory and limb muscles, is a common systemic manifestation in COPD patients.
• Lower limb muscles are more severely impacted than upper limb and respiratory muscles, leading to reduced exercise tolerance and quality of life.

Purpose of the Study:

• To review epidemiological features of COPD muscle dysfunction.
• To discuss etiologic factors and biological mechanisms underlying muscle impairment in COPD.
• To review current therapeutic strategies for managing muscle dysfunction in COPD patients.

Main Methods:

• Epidemiological review of COPD muscle dysfunction.
• Discussion of etiological factors and biological mechanisms.
• Review of therapeutic interventions including exercise, stimulation, pharmacological, nutritional, and surgical approaches.

Main Results:

• Muscle mass loss and impaired function are significant in COPD, affecting survival and quality of life.
• Lower limb muscles show more severe dysfunction compared to upper limb and respiratory muscles.
• Current treatments include exercise, neuromuscular stimulation, nutritional support, and surgery.

Conclusions:

• Body composition and quadriceps strength assessment are recommended for early COPD detection and management.
• Further research into molecular mechanisms is needed for novel therapeutic targets.
• Exercise and nutritional support represent the optimal treatment strategy for improving muscle health and quality of life in COPD.